✦ LIBER ✦

Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential

✍ Scribed by Robet.A. Olie; Uwe Zangemeister-Wittke

Book ID: 117836190
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 171 KB
Volume: 4
Category: Article
ISSN: 1368-7646
DOI: 10.1054/drup.2001.0181

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum: Targeting tumour cell resistanc

Erratum: Targeting tumour cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Treatment with siRNA and antisense oligo

Treatment with siRNA and antisense oligonucleotides targeted to HIF-1α induced apoptosis in human tongue squamous cell carcinomas

✍ Qunzhou Zhang; Zuo-Feng Zhang; Jian Y. Rao; J. Denry Sato; Jimmy Brown; Diana V. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 300 KB

## Abstract Overexpression of hypoxia inducible factor‐1α (HIF‐1α) in cancers has been correlated to a more aggressive tumor phenotype. We investigated the effect of HIF‐1α knockout on the __in vitro__ survival and death of human tongue squamous cell carcinomas (SCC‐4 and SCC‐9). Under normoxic con

Renal cell carcinoma: Resistance to ther

Renal cell carcinoma: Resistance to therapy, role of apoptosis, and the prognostic and therapeutic target potential of TRAF proteins

✍ R. Rajandram; N.C. Bennett; C. Morais; D.W. Johnson; G.C. Gobe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 313 KB

Resistance to taxanes is induced by c-er

Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A

✍ Fortunato Ciardiello; Rosa Caputo; Grazia Pomatico; Michelino De Laurentiis; Sab 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 122 KB

We have tested the sensitivity of human MCF-10A mammary epithelial cells and of their transformed derivatives overexpressing an activated c-Ha-ras gene (MCF-10A Ha-ras cells), the c-erbB-2 gene (MCF-10A c-erbB-2 cells) or both genes (MCF-10A HE cells) to different cytotoxic drugs. As compared with p